Evidence map›Paper›PMID 41089200›Full record

ArticleExperimental and therapeutic medicine2025

Refractory pleural effusion in malignant hypertension leading to an unexpected diagnosis of tuberculosis: A case report.

Hiroki Ito, Kentaro Yano, Yuya Suzuki, Yoshitaka Taniguchi, Fumiya Sato, Shigemitsu Sato, Takuo Hirose, Ikuko Oba-Yabana, Takefumi Mori

Abstract readCase Reports
In one paragraph

Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroki ItoDivision of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Kentaro YanoDivision of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Yuya SuzukiDivision of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Yoshitaka TaniguchiDivision of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Fumiya SatoDivision of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Shigemitsu SatoDivision of Integrative Renal Replacement Therapy, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Takuo HiroseDivision of Integrative Renal Replacement Therapy, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Ikuko Oba-YabanaDivision of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Takefumi MoriDivision of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accelerated malignant hypertension frequently manifests as multiple organ dysfunctions. However, persistent symptoms despite appropriate antihypertensive therapy warrant investigation of concurrent pathologies, particularly in patients with risk factors for opportunistic infections. A 57-year-old woman with untreated hypertension presented in August 2024, with markedly elevated blood pressure (208/122 mmHg), systolic dysfunction (ejection fraction, 42.5%) and acute kidney injury (creatinine 4.74 mg/dl). Accelerated malignant hypertension with multiple organ damage was diagnosed based on these findings. Despite optimal antihypertensive and diuretic therapy, pleural effusion and renal function progressively worsened. Thoracentesis revealed a lymphocyte-predominant exudative effusion with elevated adenosine deaminase levels. Subsequent investigations confirmed tuberculous pleuritis and peritonitis, ultimately diagnosed as miliary tuberculosis. Excessive diuretic therapy for presumed heart failure-related effusion exacerbates renal injury. Following initiation of antituberculous therapy, pleural effusion and renal function markedly improved. This case emphasizes the importance of reevaluating initial diagnoses when the clinical responses are suboptimal. In patients with multiple risk factors, particularly diabetes mellitus and kidney dysfunction, concurrent tuberculosis should be considered for treatment-refractory symptoms.

Indexed as

acute kidney injurymalignant hypertensionpleural effusiontuberculosistuberculous pleuritis

Identifiers

PMID41089200
PMCPMC12516476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.